Germany’s Federal Cartel Office has reportedly cleared medical equipment maker B. Braun to increase its stake in hospital operator Rhoen-Klinikum to 25 percent, according to reports.
B. Braun requested regulatory clearance for the deal last month as part of an effort to prevent the hospital operator’s takeover by rival Fresenius. Despite the efforts, since a deal with B. Braun was struck, reports say Rhoen and Fresenius have struck their own deal that sees Fresenius acquire most of Rhoen hospitals.
As such, reports are now questioning whether B. Braun will continue with the deal to increase its stake in Rhoen; a company spokesperson declined to comment on that matter.
B. Braun acquired a 5 percent share of Rhoen last year.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI